BH3-profiling of cell lines and patient samples has demonstrated that while T-ALL is primarily dependent on BCL-XL, ETP-ALL is dependent instead on BCL-2 with in vitro and in vivo sensitivity to BCL-2 inhibition [122]. This evidence concerns the gene BCL2L1 and acute lymphoblastic leukemia.